Triple-negative breast cancers (TNBC), a subtype of breast cancer that is characterized by absence of estrogen receptors (ER), progesterone receptors (PR), and a lack of overexpression of human epidermal growth factor receptor 2 (HER2), account for about 15% of all breast cancer cases [2]. Here, ERBB2 is linked to breast cancer.